News News Select Year All Years 2026 (30) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 502 Results Page 40 of 51« First«...102030...3839404142...50...»Last » July 2, 2015 DBV Technologies announces the filing of a registration statement on Form F-1 in view of an offering of new shares in the form of American Depositary Shares, as well as the filing of its Reference Document July 2, 2015 Half year update on the DBV Technologies liquidity agreement June 30, 2015 DBV Technologies Announces Completion of Part A of the MILES Study Evaluating the Safety of Viaskin® Milk in Pediatric Cow’s Milk Allergy June 26, 2015 DBV Technologies Proudly Welcomes Dr. Hugh Sampson as Chief Scientific Officer June 23, 2015 DBV Technologies’ June 23, 2015 Combined Shareholders’ Meeting June 23, 2015 DBV Technologies Confirms Planned Initiation of Viaskin® Peanut Global Phase III Clinical Trial in Children Following Endof-Phase II Meeting with FDA and PIP approval by EMA June 10, 2015 Key Scientific Data Demonstrating that Epicutaneous Administration May Reactivate Protective Immunity against Pertussis in an experimental model published in Vaccine June 8, 2015 DBV Technologies Presents Clinical and Scientific Data at the EAACI Congress June 8, 2015 DBV Technologies Presents Clinical and Scientific Data at the EAACI Congress June 4, 2015 DBV Technologies Announces EMA Paediatric Committee (PDCO) positive opinion on the Paediatric Investigation Plan for Viaskin® Peanut for the Treatment of Peanut Allergic Children Page 40 of 51« First«...102030...3839404142...50...»Last »
